P-055: TRIAL IN PROGRESS: A PHASE 2, OPEN-LABEL STUDY EVALUATING THE SAFETY AND EFFICACY OF THE ERYTHROCYTE PYRUVATE KINASE ACTIVATOR ETAVOPIVAT IN PATIENTS WITH THALASSEMIA OR SIC...

por T., COATES, A., LAL, R., BROWN, T., KALFA, J., KWIATKOWSKI, J., BREVARD, C., TRENOR, K., WOOD, S., SHETH
Publicado 2022

The impact of COVID-19 on income and employment and willingness to become vaccinated among African Americans enrolled in a smoking cessation randomized trial

por Cruvinel, Erica, P Richter, Kimber, S Scheuermann, Taneisha, M Machado, Nathalia, Mayo, Matthew S, R Brown, Alexandra, L Nollen, Nicole
Publicado 2022

O-03: ETAVOPIVAT TREATMENT FOR UP TO 12 WEEKS IN PATIENTS WITH SICKLE CELL DISEASE IS WELL TOLERATED AND IMPROVES RED BLOOD CELL HEALTH

por M., TELEN, R., BROWN, R., HAGAR, M., IDOWU, I., OSUNKWO, T., KALFA, F., KUYPERS, J., GEIB, P., SCHROEDER, E., WU, P., KELLY, S., SARAF
Publicado 2022

P644: IBRUTINIB DOSE MODIFICATIONS FOR MANAGEMENT OF CARDIAC ADVERSE EVENTS IN PATIENTS WITH B-CELL MALIGNANCIES: POOLED ANALYSIS OF 10 CLINICAL TRIALS

por Stephens, Deborah, R. Brown, Jennifer, MA, Shuo, Wang, Michael, Moreno, Carol, Robak, Tadeusz, Stevens, Don, Lee, Shane, Saifan, Chadi, Hsu, Emily, Patel, Sima, Burger, Jan
Publicado 2023

Detection of SARS-CoV-2 in high-efficiency particulate air (HEPA) filters of low-cost air purifiers in community-based organizations

por Clarke, Rachel D., Garba, Nana Aisha, Barbieri, Manuel A., Acuna, Leonardo, Baum, Marianna, Rodriguez, Maribel Saad, Frias, Hansel, Saldarriaga, Paulina, Stefano, Troy, Mathee, Kalai, Narasimhan, Giri, R. Brown, David
Publicado 2023

P647: RACIAL DISPARITIES IN REAL-WORLD TREATMENT PATTERNS AND OUTCOMES AMONG PATIENTS WITH CLL

por Rhodes, Joanna, Shadman, Mazyar, Lamanna, Nicole, S. Manzoor, Beenish, Coombs, Catherine, Ghosh, Nilanjan, H. Tuncer, Hande, Emechebe, Dozie, R. Brown, Jennifer, Alhasani, Hasan, Leslie, Lori, Roeker, Lindsey, Ujjani, Chaitra, Eichhorst, Barbara, Fleury, Isabelle, Skarbnik, Alan, T. Hill, Brian, Lansigan, Frederick, M. Barr, Paul, Davids, Matthew, Fox, Christopher, Choi, Yun, E. Jensen, Christopher, Schuh, Anna, Kennard, Kaitlin, Jawaid, Dureshahwar, Pivneva, Irina, Watson, Talissa, Eyre, Toby
Publicado 2023

P648: REAL-WORLD TREATMENT AND OUTCOMES OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) RECEIVING FIRST-LINE (1L) THERAPY IN THE NOVEL AGENT ERA: AN INTERNATIONAL STUDY

por Lansigan, Frederick, A. Eyre, Toby, Ghosh, Nilanjan, S. Manzoor, Beenish, C. Coombs, Catherine, Lamanna, Nicole, H. Tuncer, Hande, Emechebe, Dozie, R. Brown, Jennifer, E. Roeker, Lindsey, Ujjani, Chaitra, Alhasani, Hasan, Fleury, Isabelle, A. Leslie, Lori, Skarbnik, Alan, Rhodes, Joanna, T. Hill, Brian, M. Barr, Paul, S. Davids, Matthew, P. Fox, Christopher, Choi, Yun, Schuh, Anna, Kennard, Kaitlin, E. Jensen, Christopher, Jawaid, Dureshahwar, Sharma, Aditya, Pivneva, Irina, Watson, Talissa, Shadman, Mazyar
Publicado 2023

P639: ZANUBRUTINIB (ZANU) VS BENDAMUSTINE + RITUXIMAB (BR) IN PATIENTS (PTS) WITH TREATMENT-NAÏVE CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL): EXTENDED FOLLOW...

por Munir, Talha, Shadman, Mazyar, Robak, Tadeusz, R. Brown, Jennifer, Kahl, Brad, Ghia, Paolo, Giannopoulos, Krzysztof, Simkovic, Martin, Österberg, Anders, Laurenti, Luca, Walker, Patricia, Opat, Stephen, Ciepluch, Hanna, Greil, Richard, Hanna, Merit, Tani, Monica, Trneny, Marek, M. Brander, Danielle, W. Flinn, Ian, Grosicki, Sebastian, Verner, Emma, Tedeschi, Alessandra, De Guibert, Sophie, Tumyan, Gayane, Laribi, Kamel, Antonio Garcia Marco, Jose, LI, Jianyong, Tian, Tian, Ramakrishnan, Vanitha, Liu, Yu, Szeto, Andy, Paik, Jason, Cohen, Aileen, Tam, Constantine, Jurczak, Wojciech
Publicado 2023